Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Junior mining stock pops on rare earth results

Sean Mason Sean Mason, Freelance
0 Comments| November 25, 2010

{{labelSign}}  Favorites
{{errorMessage}}

Stockhouse Canadian Small and Micro-cap Stock Report for Thursday, November 25, 2010

TORONTO (SHfn) – Commerce Resources (TSX: V.CCE, Stock Forum) shares powered 28% higher to 88 cents on Thursday after the junior miner reported that it is in receipt of analytical results for drill holes EC10-046 and EC10-047 at its 100% owned Eldor Project in Quebec, which included 2.02% TREO (Total Rare Earth Oxides) over 303.42 metres.

As well, shares of Valdez Gold (TSX: V.VAZ, Stock Forum) soared 156% to 64 cents as the micro stock explorer and Ryan Gold announced that as initially set forth in the press release of Valdez dated September 27, 2010, they have signed a definitive agreement pursuant to which the two companies will merge. As a result of the merger, Valdez will acquire Ryan Gold's mineral interests, which include 269 claim units located 90 kilometres east of Dawson City, Yukon and five other exploration properties located east and west of Dawson City. As well, Osisko Mining (TSX: T.OSK, Stock Forum) will invest $7 million to own 12.7% of resulting company.

Meanwhile, Neptune Technologies & Bioressources (TSX: V.NTB, Stock Forum) said its subsidiary, Acasti Pharma, reported the completion of its preclinical program designed to compare the lipid management effects of Acasti's drug candidate CaPre versus prescription drug Lovaza. Blood lipids were monitored in two animal models in order to assess and compare the efficacy of CaPre and Lovaza over a 12-week treatment period. A low daily human equivalent dose of one gram CaPre reduced LDL-C (bad cholesterol) levels by 40% and increased HDL-C (good cholesterol) by 180% in a normal rat model while four grams of Lovaza did not show any significant effect. Neptune Technologies stock popped 18% to $2.30.

Shares of Macarthur Minerals (TSX: V.MMS, Stock Forum) surged 20% to $1.75 after the resource developer released a 57% increase in the Hematite-Goethite Inferred Mineral Resource estimate for its Lake Giles DSO projects located in Western Australia. The Inferred Resource estimate has increased to 18 million tonnes at 55.5% iron.

And, Canada Lithium (TSX: T.CLQ, Stock Forum) late Wednesday reported that it has entered into a $10 million private placement agreement to sell 12.5 million common shares at a price of 80 cents per share to funds managed by affiliates of BlackRock, Inc. Canada Lithium shares jumped as much as 29% to $1.48 on Thursday.

Top Canadian Small/Micro-cap Advancers (as of 4 PM Eastern)
Top Canadian Small/Micro-cap Decliners

To read more articles by Sean Mason please click here



{{labelSign}}  Favorites
{{errorMessage}}

Featured Company